← Leaderboards
David M Kranz
University Of Illinois Urbana-Champaign
$10,903,151
Attributed
$11,085,815
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $982.5K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$11,085,815 · 16
By mechanism
R01$6,182,160 · 5
R21$1,830,700 · 5
P01$1,578,618 · 1
R56$639,651 · 1
T32$538,896 · 1
R43$297,023 · 1
Top collaborators
- Adam Chervin1 shared
- Aditi Das1 shared
Most similar at University Of Illinois Urbana-Champaign
Same institution · by research overlap
- James A. Imlay$16,696,213
- John E. Cronan$18,470,144
- Yi Lu$14,507,600
- Scott Thomas Brady$13,526,503
- Benita S Katzenellenbogen$5,921,292
Others in their field
Top investigators on “Engineering”
- David Heimbrook · Leidos Biomedical Research, Inc.$265,348,415
- Francis L Halzen · University Of Wisconsin-Madison$239,306,664
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Daniel Stanzione · Arizona State University$173,674,275
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$173,157,760
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
Research focus
EngineeringAffinityT-LymphocyteT-Cell ReceptorPeptidesReceptorMutantSpecificityYeastsBaseAntigensBinding (Molecular Function)In VitroPeripheralMalignant NeoplasmsTumorComplexProtein EngineeringSurfaceCollectionReceptor BindingResponseStructureInterest
Grant awards (45)
Engineering class I MHC molecules to drive enhanced anti-cancer responses$207,898
R21 · FY2022 · CA · contact PI
Engineering class I MHC molecules to drive enhanced anti-cancer responses$175,320
R21 · FY2021 · CA · contact PI
Engineering CARs against cancer-specific glycoproteins$208,452
R21 · FY2020 · CA · contact PI
Engineering CARs against cancer-specific glycoproteins$185,962
R21 · FY2019 · CA · contact PI
Engineering T Cell Receptors for Adoptive Cell Therapies$320,517
R01 · FY2018 · CA · contact PI
Biochemical Mechanism of Eicosanoid Synthesizing Enzymes$68,306
R01 · FY2018 · GM
Engineering T Cell Receptors for Adoptive Cell Therapies$320,517
R01 · FY2017 · CA · contact PI
Engineering T Cell Receptors for Adoptive Cell Therapies$320,517
R01 · FY2016 · CA · contact PI
Influence of structurally related self-peptides on T cell-mediated therapies$168,613
R21 · FY2016 · CA · contact PI
Engineering T Cell Receptors for Adoptive Cell Therapies$320,517
R01 · FY2015 · CA · contact PI
Influence of structurally related self-peptides on T cell-mediated therapies$168,613
R21 · FY2015 · CA · contact PI
Engineering T Cell Receptors for Adoptive Cell Therapies$320,517
R01 · FY2014 · CA · contact PI
Engineering T Cell Receptors for Optimal Targeting of Established Tumors$320,016
P01 · FY2012 · CA · contact PI
Ultrasensitive Detection Probes for Staphylococcus aureus Enterotoxins$297,023
R43 · FY2012 · AI
Analysis and engineering of MD-2 and related proteins from common allergens$230,104
R21 · FY2012 · AI · contact PI
Engineering T Cell Receptors for Optimal Targeting of Established Tumors$323,999
P01 · FY2011 · CA · contact PI
Analysis and engineering of MD-2 and related proteins from common allergens$194,302
R21 · FY2011 · AI · contact PI
Development of a Therapeutic for Staphylococcal Enterotoxin B$639,651
R56 · FY2010 · AI · contact PI
Engineering T Cell Receptors for Optimal Targeting of Established Tumors$342,854
P01 · FY2010 · CA · contact PI
Receptor-Based Therapeutics for Enterotoxins$296,708
R01 · FY2009 · AI · contact PI
Engineering T Cell Receptors for Optimal Targeting of Established Tumors$294,873
P01 · FY2009 · CA · contact PI
Structure, Function and Engineering of T Cell Receptors$284,309
R01 · FY2009 · GM · contact PI
Engineering T Cell Receptors for Optimal Targeting of Established Tumors$296,876
P01 · FY2008 · CA · contact PI
Receptor-Based Therapeutics for Enterotoxins$296,708
R01 · FY2008 · AI · contact PI
Structure, Function and Engineering of T Cell Receptors$284,683
R01 · FY2008 · GM · contact PI
Receptor-Based Therapeutics for Enterotoxins$302,454
R01 · FY2007 · AI · contact PI
Structure, Function and Engineering of T Cell Receptors$285,045
R01 · FY2007 · GM · contact PI
Receptor-Based Therapeutics for Enterotoxins$324,427
R01 · FY2006 · AI · contact PI
Structure, Function and Engineering of T Cell Receptors$293,920
R01 · FY2006 · GM · contact PI
T Cell Receptor - Based Assays for Cancer Diagnosis$138,356
R21 · FY2006 · CA · contact PI
Receptor-Based Therapeutics for Enterotoxins$275,013
R01 · FY2005 · AI
T Cell Receptor - Based Assays for Cancer Diagnosis$153,080
R21 · FY2005 · CA
INVESTIGATING T CELL RECEPTOR FLEXIBILITY USING FLUORESCENCE$14,421
P41 · FY2005 · RR
QUANTIFICATION OF PEPTIDE-MHC EXPRESSED ON THE SURFACE OF TUMOR CELLS$914
P41 · FY2005 · RR
Structure, Function &Engineering of Tau Cell Receptors$257,113
R01 · FY2004 · GM
INVESTIGATING T CELL RECEPTOR FLEXIBILITY USING FLUORESCENCE$1,716
P41 · FY2004 · RR
QUANTIFICATION OF PEPTIDE-MHC EXPRESSED ON THE SURFACE OF TUMOR CELLS$1,716
P41 · FY2004 · RR
Structure, Function &Engineering of Tau Cell Receptors$257,472
R01 · FY2003 · GM
Structure, Function &Engineering of Tau Cell Receptors$257,811
R01 · FY2002 · GM
ENGINEERING SINGLE CHAIN ANTI T CELL RECEPTOR ANTIBODIES$215,759
R01 · FY2002 · AI
Structure, Function &Engineering of Tau Cell Receptors$300,046
R01 · FY2001 · GM
ENGINEERING SINGLE CHAIN ANTI T CELL RECEPTOR ANTIBODIES$209,474
R01 · FY2001 · AI
CELLULAR AND MOLECULAR BIOLOGY$538,896
T32 · FY2000 · GM
ENGINEERING SINGLE CHAIN ANTI T CELL RECEPTOR ANTIBODIES$203,372
R01 · FY2000 · AI
STRUCTURE/FUNCTION AND ENGINEERING OF T CELL RECEPTORS$166,955
R01 · FY2000 · GM